[1］ Norman RJ，Dewailly D，Legro RS，et al．Polycystic ovary syndrome[J]．Lancet，2007，370：685-697．

[2］ Chen ZJ，Zhao H，He L，et al．Genome-wide association study identifies susceptibility loci for polycystie ovary syndrome on chromosonle 2p16．3，2p21 and 9q33．3[J]．Nat Genet，2011，43：55-59．

[3］ Shi Y，Zhao H，Shi Y，et al．Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome[J]．Nat Genet，2012，44：1020-1025．

[4］ Xita N，Tsatsoulis A．Review：fetal programming of polycystic ovary syndrome by androgen excess：evidence from experimental，clinical，and genetic association studies[J]．J Clin Endocrinol Metab，2006，91：1660-1666．

[5］ 杨艳，胡卫红，乔杰，等.IL1ra、TNFα、US-CRP与多囊卵巢综合征发病的相关性研究[J].中国优生与遗传杂志，2007，15（5）：35-37.

[6］ 杨艳，乔杰，李美芝.白细胞介素18、白细胞介素1β与多囊卵巢综合征发病的相关性研究[J].中国实用妇科与产科杂志，2008，24（1）：38-40.

[7］ 胡卫红，乔杰，李蓉，等.多囊卵巢综合征患者血清脂肪型脂肪酸结合蛋白水平与性激素及血脂的相关性研究[J].中华医学杂志，2006，86（45）：3186-3189.

[8］ 胡卫红，乔杰，赵淑云，等.多囊卵巢综合征患者血清单核细胞趋化蛋白-1水平与血脂代谢的相关性[J].北京大学学报（医学版），2006，38（5）：487-491.

[9］ Hu W, Qiao J, Yang Y , et al. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome[J]. Eur J Obstet Gynecol Reprod Biol，2011, 157(1):53-56.

[10］ Yang Y, Qiao J, Li R , et al. Is interleukin-18 associated with polycystic ovary syndrome?［J］.Reprod Biol Endocrinol,2011, 9:7.

[11］ Hu W, Qiao J.Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome[J]. Endocrine，2011, 40(2):196-202.

[12］ 中华医学会糖尿病学分会，中国2型糖尿病防治指南（2010年版）[J].中国糖尿病杂志，2012，20（1）：S1-S37.

[13］ Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS) [J]. Hum Reprod，2012，27(1):14-24.

[14］ Qiao J.Pay more attention to ethnic differences in polycystic ovary syndrome phenotypic expression[J].Chin Med J (Engl)，2013，126(11):2003-2006.

[15］ Li R, Qiao J, Yang D , et al.Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system[J]. Eur J Obstet Gynecol Reprod Biol，2012，163(2):165-169.

[16］ Li R, Zhang Q, Yang D , et al.Prevalence of polycystic ovary syndrome in women in China: a large community-based study[J].Hum Reprod，2013 Jun 27. [Epub ahead of print]PMID:23814096.

[17］ Zhao Y, Fu L, Li R , et al.Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis[J]. BMC Med，2012，10(1):153.

[18］ Sun L, Hu W, Liu Q , et al.Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients[J]. J Proteome Res，2012，11(5):2937-2946.

[19］ Qiao J, Feng HL.Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence[J]. Hum Reprod Update，2011, 17(1):17-33.

[20］ Yu Y, Yan J, Li M, et al.Effects of combined epidermal growth factor, brain-derived neurotrophic factor and insulin-like growth factor-1 on human oocyte maturation and early fertilized and cloned embryo development[J]. Hum Reprod，2012,27(7):2146-2159.

[21］ Qiao J, Wang L, Li R , et al.Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome[J]. Reprod Biomed Online，2008, 17(3):425-435.

[22］ Lin SL, Tu BB, Du XG, et al.Lower expression of ER-α36 is associated with the development of endometrial hyperplasia in PCOS patients[J]. Histol Histopathol，2013 May 21. [Epub ahead of print] . PMID:23690166.